2C-G-N
 | |
| Clinical data | |
|---|---|
| Other names | 2C-G-NPH; 2C-NPH; 1,4-Dimethoxynaphthyl-2-ethylamine |
| Routes of administration | Oral[1] |
| Drug class | Psychoactive drug; Stimulant; Antidepressant |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 20–30 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H17NO2 |
| Molar mass | 231.295 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2C-G-N, or 2C-G-NPH, also known as 1,4-dimethoxynaphthyl-2-ethylamine, is a psychoactive drug of the phenethylamine, 2C, and naphthylethylamine families.[1] It is the derivative of 2C-G in which the 3,4-dimethyl groups have been extended and connected to form a second benzene ring and hence has a 2-naphthalene ring system.[1] In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-N's dose as 20 to 40 mg orally and its duration as 20 to 30 hours.[1][2][3] The effects of the drug were reported to include some amphetamine-like stimulation, some possible antidepressant-like effects, "not much psychedelic" but "something really going on anyway", faint uneasiness, and "not as friendly" of effects as other 2C-G compounds.[1] Its activity was described as "on the wane" compared to other 2C-G drugs and as lasting "too long".[1] The chemical synthesis of 2C-G-N has been described.[1] The drug was first described in the literature by Shulgin in PiHKAL in 1991.[1]
See also
[edit]- 2C (psychedelics)
- Substituted naphthylethylamine
- 2C-G (2C-G-0)
- 2C-G-3 and 2C-G-5
- Ganesha and G-N
References
[edit]- ^ a b c d e f g h i Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. https://www.erowid.org/library/books_online/pihkal/pihkal031.shtml
- ^ Jacob P, Shulgin AT (1994). "Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs". In Lin GC, Glennon RA (eds.). Hallucinogens: An Update (PDF). National Institute on Drug Abuse Research Monograph Series. Vol. 146. National Institute on Drug Abuse. pp. 74–91. PMID 8742795. Archived from the original on 13 July 2025.
- ^ Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.